Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.
Jablons
D M
DM
Surgery Branch and Laboratory of Genetics, National Cancer Institute, Bethesda, Maryland 20892.
McIntosh
J K
JK
Mulé
J J
JJ
Nordan
R P
RP
Rudikoff
S
S
Lotze
M T
MT
D000818:Animals; D001685:Biological Factors / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000097:blood*; D016207:Cytokines; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D015850:Interleukin-6; D007378:Interleukins / Q000096:biosynthesis* / Q000097:blood; D051379:Mice; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D001685:Biological Factors; D014408:Biomarkers, Tumor; D016207:Cytokines; D007376:Interleukin-2; D015850:Interleukin-6; D007378:Interleukins; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons